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Introduction
Infertility is considered the main problem of many couples 
worldwide (1). Female infertility is associated with 
unpleasant social outcomes (2) and different psychological 
problems (3).
Ovarian function is the main issue that is addressed 
in counseling the infertile people who should undergo 
treatment with different protocols of ovarian stimulation 
(4,5). However, some women do not respond well 
to the standard protocol stimulation regimen and 
cannot recruit adequate follicles. According to (6), these 
patients are called ‘poor ovarian responders (PORs)’. 
In vitro fertilization (IVF) is one of the most common 
and relatively new treatments in assisted reproductive 
technologies (ARTs) and is associated with great success 
in the treatment of female infertility (7).
However, in some cases, namely, poor responders, 
the ovary does not respond appropriately to stimulation 
and ovulation induction. For instance, poor response to 
ovarian stimulation was reported in 9%-24% of patients 
who had IVF (8). Moreover, the prevalence rate may have 
been underestimated because of inadequate assessments 
(9).
It is necessary to develop specific therapeutic processes 
and therapeutic strategies to achieve better outcomes 
in the treatment of ovarian failure. Many women with 
ovarian failure need to undergo IVF which has a 
relatively high failure rate; therefore, the development of 
therapeutic approaches and interventions seems essential 
(9). The use of herbal drugs and nature-based products is 
one of the popular treatments that have recently become 
widespread. This is due to fewer side effects following the 
use of the plants in the treatment of diseases (10, 11).
Fennel (Foeniculum vulgare Mill), which is from 
family Apiaceae (Umbelliferae),  i s  a perennial plant that 
occurs in Mediterranean regions. The dried seeds of F. 
vulgare have pleasant taste and odor and are used as 
odor and taste-producing agents in food industries. In 
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addition, F. vulgare odorous seeds are used as anticancer, 
stimulant, carminative, and anti-inflammatory agents in 
different organs of the body (12,13). 
Based on Iranian traditional medicine, F. vulgare is a 
medicinal plant that is warm and dry and very effective 
in regulating female hormones. Further, F. vulgare 
seeds have certain effects such as improving menstrual 
cycles, increasing lactation, reducing the symptoms 
of dysmenorrhea, facilitating childbearing, reducing 
premenstrual syndrome, and increasing libido in women. 
Furthermore, they have estrogenic properties which 
are useful for treating gynecological diseases (14-16). 
Moreover, it prevents ovarian cysts, breast cysts, ovarian 
laziness, and infertility related ovarian laziness, all of 
which are effective in female infertility.
The cycles of treatments for infertility, especially IVF, 
are costly (17), and due to chemical drug-induced side 
effects, the therapeutic process of infertility leads to high 
levels of mental and emotional stress in women (18). 
The demographic transition in developing countries 
and the aging of the population in these countries have led 
to increased fertility problems. Given the high financial 
costs of the current methods of infertility treatment and 
the high rate of failure in advanced ages, it is important 
to evaluate the efficacy of different therapies on fertility 
results. Considering the ethnobotanical studies conducted 
in Iran and the use of F. vulgare to treat some of 
the sexual female disorders in the Iranian traditional 
medicine (19,20), the present study aimed to evaluate 
the effect of F. vulgare seed extract on fertility results of 
ARTs in women with a poor ovarian response.
Materials and Methods
In this before-after intervention, 19 eligible infertile 
women with POR referring to the Endometrium and 
Endometriosis Research Center of Hamadan, Iran were 
enrolled using the convenience sampling technique in 
April-August 2014. The inclusion criteria were having a 
history of infertility (at least 3 years) and suffering from 
POR with at least one of these criteria such as being over 
35 years and having follicle-stimulating hormone (FSH) ≥ 
10 mlU/mL on day 3 of the cycle, ovarian volume ≥3 cc, 
history of failed ART, <3-5 ovules, and previous controlled 
ovarian hyperstimulation. On the other hand, the 
exclusion criteria included FSH >20 mlU/mL at an early 
follicular phase (days 2-4), uterine anomaly or fallopian 
tube obstruction confirmed by sonohysterogram or 
hysterosalpingogram, the use of corticosteroids within the 
past three months, any pregnancy contraindications, the 
absence of an ovary, and affliction with systemic diseases.
In this study, high-performance liquid chromatography 
(HPLC) was used for the standardization of herbal 
products. The applied fennel seed was subjected 
to phytochemical screening in the Department of 
Pharmacognosy, School of Pharmacy, Hamadan University 
of Medical Sciences, Hamadan, Iran. Thus, the powdered 
seeds were subjected to hydrodistillation extraction using 
a Clevenger-type apparatus. The resulting oil was injected 
into gas chromatography-mass spectrophotometry. In 
addition, the compounds were identified based on the 
retention times of the n-alkanes, which were injected after 
the oil, under the same chromatographic conditions and 
retention indices with those reported in the literature, as 
well as by the comparison of their mass spectra with those 
held in Wiley library of mass spectra or with the published 
mass spectra. The yield of the obtained oil from the fennel 
seed was 0.45%. The main component of the oil was 
anethol, which constitutes 86.86% of the oil composition. 
Further, the microbial quality was determined by the 
standard plate count method, followed by approving their 
microbiological safety.
At baseline, the medical descriptions of all women with 
a history of unsuccessful ART were obtained after their 
referral to the studied center. Women with previous ART 
were investigated for POR according to their medical 
records. Then, the required data were gathered by a 
checklist which consisted of two sections. The first 
section was concerned with demographic characteristics, 
a history of infertility, the number of children, parity, 
previous diseases and surgery, drug-taking, a history of 
regular or irregular menstruation, and previous IVF.
These data were drawn from the patients’ medical files. 
The second section of this checklist included paraclinical 
tests such as FSH levels on day 3 of the cycle and 
luteinizing hormone ( LH), ovarian volume, the number 
of preantral follicles, endometrial thickness, and the 
number of days required for induction were measured 
(21,22) before and after treatment with boiled F. vulgare. 
Then, the serum levels of FSH, LH, and estradiol were 
measured on day 3 of the cycle, ovarian volume on day 3 
of the cycle, and mid-cycle transvaginal ultrasound.
The patients orally took 50-cc, a  single dose of 
boiled F. vulgare each night. To prepare the extract, 10 
g of the already prepared and packaged F. vulgare by the 
researchers in each turn was boiled in 250 mL water for 20 
minutes. After the 2-month treatment with F. vulgare, the 
paraclinical tests conducted at the baseline were repeated 
and then the patients underwent ovulation induction 
while they continued to take boiled F. vulgare (23).
To induce ovulation, two decapeptide ampoules (0.1 
unit) were administered to the patients on two days 
and the administration with 300-450 IU gonadotropin 
was started from the day 3 onwards and transvaginal 
ultrasound was conducted once every 3-4 days by 
the researcher under the supervision of a gynecologist 
in the studied center. This process continued until the 
follicular size reached 18 mm when 2 human chorionic 
gonadotropin (hCG) ampoules (10000 units) were 
administered to the patients. Thirty-six hours later, 
the puncture was conducted, followed by conducting 
microinjection (1-2 hour(s) later) using the processed 
sperm, transfer (48-72 hours later), and the  beta (hCG 
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test (2 weeks later) in the laboratory of the hospital.
Eventually, the data were analyzed by the paired t 
test, as well as Wilcoxon’s and McNemar tests in SPSS, 
version 16.
Results
The yield of the obtained oil from the fennel seed was 
0.45% and anethol was the main component of the oil, 
which constituted 86.86% of the oil composition (Table 1).
The mean (SD) age of the studied patients was 36.95 (6.12) 
within the range of 31-45) years. Table 2 provides further 
demographic characteristics of the patients. The mean 
number of the patients’ children the mean parity, and the 
mean number of abortions were 0.59 ± 0.37, 2.08 ± 1, and 
2.08 ± 0.68, respectively.
Wilcoxon test results demonstrated that there was a 
significant difference in the serum FSH level between 
before and after treatment with F. vulgare (P = 0.501). 
Additionally, the results of the t-test indicated a significant 
difference in the serum LH level between before and 
after treatment with F. vulgare (P = 0.002). In addition, a 
significant difference was observed in the serum FSH/HL 
level between before and after treatment with F. vulgare 
(P = 0.049), the details of which are provided in Table 3.
Further, there were significant differences in the 
number of follicles (P = 0.003), the number of ovules 
(P = 0.003), and ovarian volume (P = 0.03) in the patients 
between before and after treatment with F. vulgare. 
Based on the results of the Wilcoxon test, a significant 
difference was found in the number of days required 
for induction between before and after treatment with 
Table 1. The HPLC Analysis of Foeniculum vulgare
Compound Area %
α-Pinene 0.06
Sabinene 0.12
β-Myrcene 0.08
p-Cymene 0.03
Limonene 0.88
1,8-Cineol 0.18
Fenchone 7.43
Camphor 0.1
p-Allylanisole 1.65
E-Anethol 86.86
Thymol 1.21
Nonadecane 0.16
Tricosane 0.2
Tetracosane 0.24
Pentacosane 0.35
Bis(2-ethylhexyl)phthalate 0.45
Note. HPLC: High-performance liquid chromatography.
F. vulgare (P = 0.022). However, the results indicated no 
significant difference in the number of embryos between 
before and after treatment with F. vulgare (P = 0.677). 
Contrarily, the results of the dependent t test (Table 4) 
demonstrated a significant difference in the endometrial 
thickness between before and after treatment with F. 
vulgare (P = 0.04).
The study of the conception frequency demonstrated 
that two (10.5%) patients conceived after treatment with 
F. vulgare and before ART.
Discussion
To the best of our knowledge, the present study was the 
first one to investigate the use of the F. vulgare seed 
extract on fertility results in women with POR. The 
results demonstrated that the levels of LH and FSH/
LH increased in the patients after treatment with F. 
vulgare. This finding represents the effect of F. vulgare on 
the serum FSH/LH level that is an important factor for 
the prediction of the response to stimulation. However, 
hormonal response to t h e  serum FSH level was not 
significantly different between before and after the 
treatment. In an in vitro study, F. vulgare extract was 
found to cause an increase in the serum FSH level while a 
decrease in LH and testosterone levels in laboratory mice 
(24).
Based on the findings of this study, the number of 
ovules and follicles, ovarian volume, and endometrial 
thickness increased whereas the number of days required 
for induction decreased after treatment with F. vulgare. 
In a study conducted on laboratory female mice, it 
was demonstrated that hydroalcoholic F. vulgare seed 
Table 2. Frequency Distribution of the Patients According to the History of 
Infertility, Type of Menstruation, and Previous Surgery
Variable Number Percent (100%)
History of 
infertility
Primary 11 57.9
Secondary 8 42.1
Menstruation
Regular 17 89.5
Irregular 2 10.5
Previous 
surgery
Yes 5 26.3
 No 14 73.7
Table 3. Mean Serum Levels of LH, FSH, and FSH/LH in the Patients 
Before and After Treatment With Foeniculum vulgare
Variable
Before Treatment After Treatment
P Value
Mean ± SD Mean ± SD
FSH 8.12±4.27 7.86±2.65 0.501
LH 3.54±1.28 4.05±1.71 0.002
FSH/LH 2.48±1.61 2.51±0.96 0.049
Note. SD: standard deviation; LH: luteinizing hormone; FSH: follicle-
stimulating hormone.
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extract increased the number of antral, graafian, and 
multilaminar follicles such that the folliculogenesis and 
growth of ovarian follicles indicated an increase (25).
Obviously, the increased number of preantral follicles 
after the use of F. vulgare extract represents its positive 
effect on the ovarian reserve. It seems that the F. vulgare 
seed exerts these effects because it contains certain 
phytoestrogens such as isoflavones, prenylated flavonoids, 
and coumestans (26). Furthermore, the estrogenic activity 
of F. vulgare is due to the presence of a compound called 
“anatole”. Trans-anatole comprises over 80% of F. vulgare 
(27-29).
This compound causes a n  increase in t h e  lactation, 
t h e  relief of menstrual pain, the facilitation of 
childbearing, primary dysmenorrhea, and a decrease in 
female infertility (30,31). This is because phytoestrogens 
act similar to the estrogens in the body and cause the 
regulation of the gonad-stimulating hormone activity, 
an  increase in t h e  endometrial thickness, and finally, 
an  increase in the likelihood of fertility. Moreover, the 
antioxidant properties of the F. vulgare seed can increase 
fertility in women with POR through inhibiting cell 
destruction while increasing cell growth (15,32-34). In 
addition, low concentrations of the ethanolic F. vulgare 
seed extract help increase the alkaline phosphatase activity 
and thus cell growth and proliferation (31,35). Contrarily, 
the results demonstrated that the number of embryos did 
not change significantly after the use of F. vulgare extract 
in the studied patients, which could be due to their old age.
However, the success rate of ARTs used for infertile 
couples depends on several factors such as the selection of 
an appropriate protocol, the appropriate implementation 
of ovarian stimulation, the production of an appropriate 
ovarian response in the hormonal cycle, along with 
the number of the oocytes. POR in the IVF cycle is 
associated with a higher failure rate, a lower number of 
aspirated oocytes and transferred embryos, and therefore, 
a lower likelihood of conception (36).
In this study, two (10.5%) patients, who were above 
35 years, conceived after the use of the F. vulgare extract 
and before beginning the IVF (i.e., an ART). It seems 
that the use of F. vulgare is effective in enhancing the 
oocyte quality and thus increasing fertility likelihood in 
humans.
Although the results of this study demonstrated 
the positive effects of F. vulgare on female fertility, the 
active dose of the extract should be taken into account 
since the teratogenic side effects of this extract have 
already been discussed (37). The small sample size and 
withdrawal of a number of women (6 women) from 
continuing participation in the study are the limitations 
of the present study.
Conclusions
In general, the F. vulgare seed extract is effective in 
improving the factors for conception in women and can 
be used as a complementary therapy alongside certain 
approaches such as ARTs. This study can be considered 
as a pioneering research project regarding investigating 
the effect of F. vulgare on IVF fertility results in women 
with POR. Future studies are recommended to evaluate 
the action mechanism of ovulation of the F. vulgare seed 
and its extract active dose. In addition, similar studies 
should be conducted to investigate this issue in non-
poor responders while considering age a s  a confounder.
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